NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹202.74 | ₹233.89 | ₹127.45 | ₹49.74 | ₹62.85 |
What is the latest Earnings Per Share (EPS) of NEULAND LABORATORIES ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹202.74 |
| Mar2024 | ₹233.89 |
| Mar2023 | ₹127.45 |
| Mar2022 | ₹49.74 |
| Mar2021 | ₹62.85 |
How is Earnings Per Share (EPS) of NEULAND LABORATORIES Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹202.74 | -13.32 | |
| Mar2024 | ₹233.89 | 83.52 | |
| Mar2023 | ₹127.45 | 156.23 | |
| Mar2022 | ₹49.74 | -20.86 | |
| Mar2021 | ₹62.85 | - | |
Compare Earnings Per Share (EPS) of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹16,852.4 Cr | 9.6% | 1% | 3.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,326.0 Cr | -5.7% | -3.3% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,282.0 Cr | -3.1% | -9.3% | 0% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,043.0 Cr | -6.1% | -8.3% | 23.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,854.2 Cr | -5.1% | -6% | 4.8% | Stock Analytics | |
| CIPLA | ₹97,115.7 Cr | -3.3% | -11.2% | -19.5% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 9.6% |
1% |
3.4% |
| SENSEX | 1.4% |
-7% |
-3.9% |
You may also like the below Video Courses